Delivery Order SPE2DB22D3004-SPE2DB25FPG67
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a $1,148.70 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp for the supply of 4,565,814,685 units of Clindamycin HCL 150 mg capsules. This contract has an ultimate completion date of September 17, 2024 and does not include a set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple indefinite delivery contracts (IDCs) by DLA and other federal agencies to provide a wide range of...
- This federal contract award, valued at $1,180.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4554491622 - Clindamycin HCL 300 mg capsules in 100-count packages. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with a ceiling value of $999,999,999.00 running through...
- This federal contract award is for the delivery of 4,554,462,418 units of Clindamycin HCL 300 mg capsules in 100 count bottles. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 18, 2021. The contract has a ceiling value of $1,239.28 and is a firm fixed-price delivery order. There was no set-aside designation for this award. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit...
- This federal contract award, with the ID SPE2DB20D7059|SPE2DB25FQAQ8, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4567351695 ! CLINDAMYCIN (PEDI) 75 MG/5 ML 100ML, a pharmaceutical product, with a ceiling value of $1,510.08. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award is for the delivery of CLINDAMYCIN PH 900 MG/6 ML VL 6ML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract has a ceiling value of $4,627.25 and is structured as a Firm Fixed Price Delivery Order, with an ultimate completion date of May 14, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken,...
- This federal contract award is for the delivery of CLINDAMYCIN QS 100ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,898.28 and an ultimate completion date of June 20, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. This contract is not set-aside and was awarded on May 22, 2025....
- This federal contract award is a delivery order valued at $15,053.24 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a large pharmaceutical distribution company. The award is for the provision of 4,558,161,196 units of the medication Clindamycin HCL 300 mg capsules. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical worth up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Clindamycin 150mg pharmaceutical products, with a ceiling value of $6,626.06 and an ultimate completion date of August 7, 2024. The contract is a Delivery Order issued under an existing Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA,...
- This federal contract award, valued at $1,246.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CLINDAMYCIN 600 MG/50 ML-D5W 50ML, a medical product, with a completion date of January 30, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds...
- This federal contract award, valued at $1,154.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Clindamycin 900 mg/50 ml-D5W 50 ml, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FPG67Delivery Order
This federal contract award, with ID SPE2DB22D3004|SPE2DB25FPG67, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4567067336 - CLINDAMYCIN HCL 150 MG CAPSULE 100S, with a ceiling value of $1,273.96 and a completion date of January 29, 2025. The contract type is Delivery Order, with a Firm Fixed Price pricing structure. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 1/28/25 |